Kinepolis Group (KIN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
10 Dec, 2025Executive summary
Achieved strong annual results in 2024, with a record-breaking second half offsetting a weak first half impacted by the Hollywood strike and content shortages, resulting in a 7.9% decline in visitors but only a 4.5% revenue drop year-over-year.
Premiumization and higher in-theatre consumption led to increased revenue per visitor, with premium concepts in the U.S. and Canada driving higher market share and revenue.
Free cash flow reached an all-time high of €98.3m, up 15%, despite increased maintenance investments, supporting a stable dividend proposal of €0.55 per share.
Net financial debt reduced to €319.3m from €378.3m, with leverage at 2.25x, indicating improved financial health.
Continued expansion and innovation with new premium formats, cinema openings, and technology upgrades, regaining pre-pandemic financial performance.
Financial highlights
Revenue: €578.2m (-4.5% YoY); visitors: 32.6m (-7.9% YoY); adjusted EBITDA: €167.3m (-11.1% YoY); adjusted EBITDAL: €132.7m (-13.1% YoY).
Adjusted EBITDA margin: 28.9% (down from 31.1%); EBIT margin: 14.2% (down from 17.5%).
Free cash flow: €98.3m (+15% YoY); cash conversion: 75%.
Net financial debt (excl. leases): €319.3m (down from €378.3m); leverage: 2.25x.
Dividend proposed at €0.55 per share, unchanged from 2023.
Outlook and guidance
2025 profit plan targets same EBITDA with 5% fewer tickets, continuing the annual 5% efficiency challenge.
Anticipates further growth driven by innovation, premium concepts, and an expanded Hollywood film slate in 2025, with gradual recovery in visitor numbers.
Internal expansion and premiumization initiatives to drive incremental revenue per visitor.
CapEx guidance for 2025 expected to be in line with 2024, excluding external expansion.
Kinepolis expects to maintain pre-pandemic performance despite a slower Hollywood recovery.
Latest events from Kinepolis Group
- Profitability held firm in 2025 as premiumization and expansion offset lower attendance.KIN
Q4 20252 Mar 2026 - Revenue up 6.2% and adjusted EBITDAL up 22.6% on strong attendance and premiumization.KIN
Q2 202523 Nov 2025 - Visitor numbers fell 11.1% in Q3, but premium experiences boosted revenue per visitor.KIN
Q3 202523 Oct 2025 - Premium strategy drove record spend per visitor despite lower attendance in Q3 2024.KIN
Q3 202413 Jun 2025 - Revenue and profit fell on lower attendance, but premium offerings and H2 recovery expected.KIN
Q2 202413 Jun 2025 - Visitor numbers fell in Q1, but premiumisation and a strong film slate boost outlook.KIN
Q1 20256 Jun 2025